19:25:36 EDT Mon 23 May 2022
Enter Symbol
or Name

Login ID:
Bioharvest Sciences Inc
Symbol BHSC
Shares Issued 431,499,251
Close 2021-07-08 C$ 0.45
Recent Sedar Documents

Bioharvest grants options to buy 423,000 shares

2021-07-09 09:10 ET - News Release

Subject: Press Release/News Attached for Dissemination on Stockwatch.com Word Document File: '\\doc\emailin\20210709 055755 Attachment 070921 BHSC NR Grant of Stock Option 423,000.docx' CSE:BHSC - FSE:8MV NR: 1-070921 BIOHARVEST SCIENCES INC. ANNOUNCES GRANT OF STOCK OPTIONS Vancouver, BC / July 9, 2021 / BioHarvest Sciences Inc. ("BioHarvest" or the "Company") (CSE: BHSC) announces that is has granted of a total of 423,000 stock options to employees and consultants. The stock options granted are exercisable to purchase a common share of the Company at a price of $0.45 per share for a term of 10 years. 370,000 stock options granted will vest quarterly over a 3-year period and 53,000 will vest monthly over a 4-month period. About BioHarvest Sciences Inc. Based in Vancouver, BC, BioHarvest Sciences Inc. is the developer and exclusive owner of the proprietary and patent-protected BioFarming technology. It is the first and only industrial-scale plant cell technology capable of producing the active plant ingredients without the necessity to grow the plant itself. The Company's technology is non-GMO and has already been validated by VINIA(TM), the red grapes cells functional food/dietary supplement produced and sold by BioHarvest Sciences Inc. The Company plans to generate significant revenue within the global nutraceutical ingredients and dietary supplements market with VINIA(TM) and other Super Fruit Nutraceutical products. Further, by adapting this technology to the cannabis plant, and building adequate production capacity, BioHarvest Sciences Inc.'s objective is to also become a leading supplier of cannabis for both medicinal and legal recreational purposes. For more information visit: www.bioharvest.com. BioHarvest Sciences Inc. Ilan Sobel, Chief Executive Officer For further information, please contact: Dave Ryan, VP Investor Relations & Director Phone: 1 (604) 622-1186 Email: dave@bioharvest.com Forward-Looking Statements Information set forth in this news release includes forward-looking statements that are based on management's current estimates, beliefs, intentions, and expectations, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. There is no assurance that we will achieve our objective of being a leading supplier of Cannabis. Delays and cost overruns may result in delays achieving our objectives. Projected sales of Cannabis will require the company to obtain production and / or export licensing which cannot be assured. All forward-looking statements are inherently uncertain and actual results may be affected by a number of material factors beyond our control. Readers should not place undue reliance on forward-looking statements. BHSC does not intend to update forward-looking statement disclosures other than through our regular management discussion and analysis disclosures. Neither the Canadian Securities Exchange nor its Regulation Services Provider accept responsibility for the adequacy or accuracy of this release.

© 2022 Canjex Publishing Ltd. All rights reserved.